Literature DB >> 15016363

ADP-ribosyl cyclase; crystal structures reveal a covalent intermediate.

Michael L Love1, Doletha M E Szebenyi, Irina A Kriksunov, Daniel J Thiel, Cyrus Munshi, Richard Graeff, Hon Cheung Lee, Quan Hao.   

Abstract

ADP-ribosyl cyclase catalyzes the elimination of nicotinamide from NAD and cyclization to cADPR, a known second messenger in cellular calcium signaling pathways. We have determined to 2.0 A resolution the structure of Aplysia cyclase with ribose-5-phosphate bound covalently at C3' and with the base exchange substrate (BES), pyridylcarbinol, bound to the active site. In addition, further refinement at 2.4 A resolution of the structure of nicotinamide-bound cyclase, which was previously reported, reveals that ribose-5-phosphate is also covalently bound in this structure, and a second nicotinamide site was identified. The structures of native and mutant Glu179Ala cyclase were also solved to 1.7 and 2.0 A respectively. It is proposed that the second nicotinamide site serves to promote cyclization by clearing the active site of the nicotinamide byproduct. Moreover, a ribosylation mechanism can be proposed in which the cyclization reaction proceeds through a covalently bound intermediate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15016363     DOI: 10.1016/j.str.2004.02.006

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  8 in total

1.  Porcine CD38 exhibits prominent secondary NAD(+) cyclase activity.

Authors:  Kai Yiu Ting; Christina F P Leung; Richard M Graeff; Hon Cheung Lee; Quan Hao; Masayo Kotaka
Journal:  Protein Sci       Date:  2016-01-12       Impact factor: 6.725

2.  Characterization of Streptococcus pyogenes beta-NAD+ glycohydrolase: re-evaluation of enzymatic properties associated with pathogenesis.

Authors:  Joydeep Ghosh; Patricia J Anderson; Sukantha Chandrasekaran; Michael G Caparon
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

3.  Mechanism of cyclizing NAD to cyclic ADP-ribose by ADP-ribosyl cyclase and CD38.

Authors:  Richard Graeff; Qun Liu; Irina A Kriksunov; Masayo Kotaka; Norman Oppenheimer; Quan Hao; Hon Cheung Lee
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

4.  Redesign of Schistosoma mansoni NAD+ catabolizing enzyme: active site H103W mutation restores ADP-ribosyl cyclase activity.

Authors:  Isabelle Kuhn; Esther Kellenberger; Didier Rognan; Frances E Lund; Hélène Muller-Steffner; Francis Schuber
Journal:  Biochemistry       Date:  2006-10-03       Impact factor: 3.162

5.  The calcium-mobilizing messenger nicotinic acid adenine dinucleotide phosphate participates in sperm activation by mediating the acrosome reaction.

Authors:  Sridhar R Vasudevan; Alexander M Lewis; Jennifer W Chan; Claire L Machin; Debroshi Sinha; Antony Galione; Grant C Churchill
Journal:  J Biol Chem       Date:  2010-04-16       Impact factor: 5.157

6.  Aberrant cyclization affords a C-6 modified cyclic adenosine 5'-diphosphoribose analogue with biological activity in Jurkat T cells.

Authors:  Christelle Moreau; Tanja Kirchberger; Bo Zhang; Mark P Thomas; Karin Weber; Andreas H Guse; Barry V L Potter
Journal:  J Med Chem       Date:  2012-02-08       Impact factor: 7.446

7.  Characterization of an Immunodominant Epitope in the Endodomain of the Coronavirus Membrane Protein.

Authors:  Hui Dong; Xin Zhang; Hongyan Shi; Jianfei Chen; Da Shi; Yunnuan Zhu; Li Feng
Journal:  Viruses       Date:  2016-12-10       Impact factor: 5.048

8.  The CD38/CD157 mammalian gene family: An evolutionary paradigm for other leukocyte surface enzymes.

Authors:  Silvia Deaglio; Fabio Malavasi
Journal:  Purinergic Signal       Date:  2006-05-30       Impact factor: 3.765

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.